SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 30.89+3.6%12:32 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bluegreen who wrote (16059)9/20/2002 11:22:07 PM
From: Cacaito  Read Replies (2) of 17367
 
11,000 subjects trial, Lilly is going to expend some $100M in Xigris trial, even if they do not get improvement in subjects it will pay for Lly if they just prove no harm it is open highway for the drug in the subjects were proven effective.

Bpi is on a leash and on meager diet, thanks to bax. Sad.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext